All Stories

  1. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Tommaso Angelone, CARMINE ROCCA, Angelo Corti